P&G's EPS Growth Narrative Faces Reality Check as Margins Erode

What happened

A Zacks Investment Research article questions whether Procter & Gamble can sustain its EPS growth, citing reliance on pricing power and cost discipline amid potential near-term pressure. The DeepValue report confirms these concerns, with FQ2’26 results showing flat organic sales, a 1% price increase offset by a 1% volume decline, and a sharp 200 basis-point drop in operating margin to 24.2%. This margin erosion stems from headwinds like tariffs, product mix, and reinvestment costs, which overwhelmed +170 bps of manufacturing productivity, highlighting a disconnect between management's digital upgrade narrative and actual profit generation. Despite P&G's emphasis on defensive measures, the data reveals that productivity gains are being consumed rather than flowing to the bottom line, undermining the EPS growth story. Investors must now assess whether operational leverage can be restored before committing to a stock priced for resilience.

Implication

The key implication is that P&G's stock, trading at 22.3x P/E, is priced for defensive durability while recent filings show margin compression and lack of operational leverage, creating downside risk if trends persist. With operating income declining 3% YoY in the six months ended Dec. 2025 and headwinds like tariffs and mix ongoing, the bear case scenario of $135 becomes more plausible if pricing turns negative in key segments. Investors must monitor near-term catalysts, such as the next quarterly margin bridge and the Glad JV termination's cash infusion, but these may offer only temporary relief without addressing structural issues like competitive intensity and reinvestment costs. Therefore, aligning with the WAIT rating, a cautious approach is warranted until proof emerges that productivity translates to profit growth and pricing remains positive. This stance is reinforced by the Zacks article's focus on slowing EPS growth, emphasizing the need for patience and critical scrutiny of management's execution.

Thesis delta

The DeepValue report maintains a WAIT thesis, arguing that P&G is overvalued given its failing margin defense and lack of operational leverage in recent results. The Zacks article amplifies this by questioning EPS growth sustainability, suggesting that near-term pressures could delay any positive inflection and validate the report's cautious outlook. This delta reinforces the need for investors to see concrete improvement in pricing power and productivity translation before considering a more bullish stance.